Erythromycin and ciprofloxacin resistance in Campylobacter jejuni isolated in Sør-Trøndelag County, Norway;Erytromycin- og ciprofloksacinresistens hos Campylobacter jejuni

Tidsskrift for den Norske Laegeforening

Volumn 121, Issue 18, 2001, Pages 2152-2154

  Afset, Jan Egil ^a   Mæland, Johan A ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; CAMPYLOBACTER JEJUNI; DIARRHEA; DRUG EFFECT; DRUG INDICATION; HUMAN; NONHUMAN; NORWAY; RETROSPECTIVE STUDY;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CIPROFLOXACIN; DIARRHEA; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; RETROSPECTIVE STUDIES;

EID: 14344269993     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hasseltvedt V, Kapperud G. Campylobacteriose i Norge i 1999. MSIS-rapport 2000; 28: 31.
2. Nachamkin I, Engberg J, Møller Aarestrup F. Diagnosis and antimicrobial susceptibility of campylobacter species. I: Nachamkin I, Blaser MJ, red. Campylobacters. 2. utg. Washington: ASM Press, 2000: 69-88.
3. Ruiz J, Goñi P, Marco F, Gallardo F, Mirelis B, Jiminez De Anta T et al. Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Immunol 1998; 42: 223-6.
4. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clin Infect Dis 1998; 26: 341-5.
5. Sjögren E, Lindblom GB, Kaijser B. Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. J Antimicrob Chemother 1997; 40: 257-61.
6. Digranes A, Melby KK, red. Susceptibility testing of bacteria and fungi. Report from «The Norwegian working group on antibiotics». Scand J Infect Dis 1997; 34 (suppl 103): 1-36.
7. Kapperud G, Lassen J, Ostroff SM, Aasen S. Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis 1992; 24: 741-9.
8. Aavitsland P, Leegaard T. Kinolonresistens hos Campylobacter jejuni skyldes antibiotika til dyr. Resistens 1999; 3: 7-8.
9. Adler-Mosca H, Lüthy-Hottenstein J, Lucchini GM, Burnens A, Altwegg M. Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or cipro-floxacin. Eur J Clin Microbiol Infect Dis 1991; 10: 953-7.
10. Ellis-Pegler RB, Hyman LK, Ingram RJH, McCarthy M. A placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhoea in the community. J Antimicrob Chemother 1995; 36: 259-63.
11. Bremón AR, Ruiz-Tovar M, Gorricho BP, de Torres PD, Rodríguez RL. Non-hospital consumption of antibiotics in Spain: 1987-1997. J Antimicrob Chemother 2000; 45: 395-400.
12. Øydvin K, red. Legemiddelforbruket i Norge 1990-1994. Oslo: Norsk medisinaldepot, 1995.
13. Øydvin K, red. Legemiddelforbruket i Norge 1995-1999. Oslo: Norsk medisinaldepot, 2000.
14. Smith KE, Bender JB, Osterholm MT. Antimicrobial resistance in animals and relevance to human infections. I: Nachamkin I, Blaser MJ, red. Campylobacters. 2. utg. Washington: ASM Press, 2000: 483-95.
15. Smith KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999; 340: 1525-32.
16. Grave K, Rønning M. Forbruk av veterinære antibakterielle midler i Norge i perioden 1995-1999 med spesiell vekt på produksjonsdyr. Norsk Veterinærtidsskrift 2000; 112: 235-40.
17. Roksvaag PO, red. Bruk av antibakterielle midler til produksjonsdyr. Nytt om legemidler 1998; 21 (suppl 1): 5-19.
18. Sáenz Y, Zarazaga M, Lantero M, Gastañares MJ, Baquero F, Torres C. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 2000; 44: 267-71.
19. Gaudreau C, Gilbert H. Comparison of disc diffusion and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni subsp. jejuni and Campylobacter coli. J Antimicrob Chemother 1997; 39: 707-12.